Large-scale testing (Phase 3)Study completedNCT04224194What this trial is testingAuto-injector Real Life Handling in PatientsWho this might be right forRA Alvotech Swiss AG 107
Early research (Phase 1)Ended earlyNCT04255862What this trial is testingEvaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study ParticipantsWho this might be right forHealthy Study Participants UCB Biopharma SRL 71
Not applicableStudy completedNCT06737796What this trial is testingThe Effect of Different Feeding Methods on InfantsWho this might be right forPreterm InfantsInjectorFinger+2 more Aydin Adnan Menderes University 74
Large-scale testing (Phase 3)Study completedNCT06471361What this trial is testingEvaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis UCB Biopharma SRL 31
Early research (Phase 1)Study completedNCT06511076What this trial is testingEvaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult ParticipantsWho this might be right forHealthy Volunteers UCB Biopharma SRL 14
Not applicableStudy completedNCT02669901What this trial is testingNaloxone Auto-injector as a Universal Precaution for Patients With Opioid Use DisorderWho this might be right forOpiate Antagonist OverdoseOpioid-Related Disorders University of New Mexico 395
Not applicableStudy completedNCT00983775What this trial is testingPharmacology of Insulin Injected With Jet-InjectionWho this might be right forDiabetes Mellitus, Type 1 Radboud University Medical Center 48
Early research (Phase 1)Study completedNCT05283681What this trial is testingEvaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult ParticipantsWho this might be right forHealthy Volunteers AbbVie 226
Early research (Phase 1)Study completedNCT06937619What this trial is testingAssess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult ParticipantsWho this might be right forHealthy Volunteer AbbVie 263
Early research (Phase 1)Study completedNCT05405985What this trial is testingStudy to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber SyringeWho this might be right forHealthy Volunteers Galderma R&D 192
Testing effectiveness (Phase 2)UnknownNCT00874835What this trial is testingCorneal Endothelium Delivery InstrumentWho this might be right forCorneal Transplantation Ocular Systems, Inc. 100
Large-scale testing (Phase 3)Study completedNCT03014674What this trial is testingCompare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised DrugWho this might be right forAsthma GlaxoSmithKline 246
Testing effectiveness (Phase 2)Active Not RecruitingNCT06293365What this trial is testingTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune DiseaseWho this might be right forSjögrens DiseaseSystemic Lupus ErythematosusRheumatoid Arthritis Novartis Pharmaceuticals 155
Large-scale testing (Phase 3)Study completedNCT01879319What this trial is testingStudy to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/PenWho this might be right forPrimary HypercholesterolemiaMixed Dyslipidemia Amgen 164
Early research (Phase 1)Ended earlyNCT05813314What this trial is testingBioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy ParticipantsWho this might be right forAchondroplasia BioMarin Pharmaceutical 36
Post-approval studies (Phase 4)Study completedNCT02253407What this trial is testingSafety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old ChildrenWho this might be right forImmune Response to MMR Vaccine Serum Institute of India Pvt. Ltd. 341
Not applicableStudy completedNCT05129241What this trial is testingNon-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injectorWho this might be right forPrimary Hypercholesterolaemia and Mixed DyslipidaemiaAtherosclerotic Cardiovascular Disease Sanofi 163
Early research (Phase 1)Study completedNCT04018599What this trial is testingComparison of PK and Tolerability of MSB11022 Administered by AI or PFSWho this might be right forRheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more Fresenius Kabi SwissBioSim GmbH 216
Early research (Phase 1)Study completedNCT04679623What this trial is testingStudy of Midazolam in Healthy AdultsWho this might be right forStatus Epilepticus Rafa Laboratories 40
Large-scale testing (Phase 3)Ended earlyNCT01676701What this trial is testingEvaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis Eli Lilly and Company 8